Abionic teams up with Genentech to develop rapid Asthma test

Abionic teams up with Genentech to develop rapid Asthma test

05.9.2019 – Abionic has signed an agreement with Genentech to develop and provide rapid Point-of-Care tests for Asthma in the US. The pre-market process for the specific asthma panel will be managed by Abionic while Genentech will fund clinical and regulatory costs.

read more…